Probably would have been the intention post-approval regardless, seems fairly common for Aussie bio/pharma companies. We’re not even at that stage yet though, more likely end up selling this to a US player by the end of the year
- Forums
- ASX - By Stock
- Opthea (OPT) - The BREAKTRHOUGH in Vision Treatment IMMINENT
OPT
opthea limited
Add to My Watchlist
0.00%
!
60.0¢

Probably would have been the intention post-approval regardless,...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
60.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $738.7M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
OPT (ASX) Chart |
Day chart unavailable